Anaesthesia for a patient with Down's syndrome and Eisenmenger's complex

Area of Science:

• Anesthesiology
• Cardiology
• Genetics

Background:

• Down syndrome and Eisenmenger complex present significant anesthetic challenges.
• Patients with Eisenmenger complex require careful management of pulmonary and systemic vascular resistance.
• General anesthesia is often feasible but necessitates meticulous hemodynamic monitoring and drug selection.

Observation:

• A patient with Down syndrome and Eisenmenger complex received metaraminol during pre-oxygenation for elbow surgery.
• Immediate adverse effects included bradycardia, mild hypertension, and profound cyanosis.
• Intravenous atropine administration led to rapid clinical improvement.

Findings:

• Metaraminol, a vasoactive agent, can precipitate severe adverse reactions in patients with Eisenmenger complex.
• The combination of Down syndrome and Eisenmenger complex may increase sensitivity to certain anesthetic agents.
• Atropine effectively reversed the metaraminol-induced bradycardia and associated complications.

Implications:

• Avoidance of potent vasoactive drugs like metaraminol is crucial in patients with Eisenmenger complex unless strictly indicated.
• Anesthesiologists must exercise extreme caution when administering any vasoactive substances to patients with complex congenital heart disease.
• This case underscores the importance of individualized anesthetic management and preparedness for adverse events in high-risk patient populations.